63 related articles for article (PubMed ID: 11354935)
1. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women.
Segraves RT; Croft H; Kavoussi R; Ascher JA; Batey SR; Foster VJ; Bolden-Watson C; Metz A
J Sex Marital Ther; 2001; 27(3):303-16. PubMed ID: 11354935
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.
Safarinejad MR; Hosseini SY; Asgari MA; Dadkhah F; Taghva A
BJU Int; 2010 Sep; 106(6):832-9. PubMed ID: 20151970
[TBL] [Abstract][Full Text] [Related]
3. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women.
Segraves RT; Clayton A; Croft H; Wolf A; Warnock J
J Clin Psychopharmacol; 2004 Jun; 24(3):339-42. PubMed ID: 15118489
[TBL] [Abstract][Full Text] [Related]
4. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.
Safarinejad MR
J Psychopharmacol; 2011 Mar; 25(3):370-8. PubMed ID: 20080928
[TBL] [Abstract][Full Text] [Related]
5. The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.
Kingsberg SA; Clayton AH; Pfaus JG
CNS Drugs; 2015 Nov; 29(11):915-33. PubMed ID: 26519340
[TBL] [Abstract][Full Text] [Related]
6. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
[TBL] [Abstract][Full Text] [Related]
8. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
9. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
Parish SJ; Hahn SR
Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
[TBL] [Abstract][Full Text] [Related]
10. Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment.
Warnock JJ
CNS Drugs; 2002; 16(11):745-53. PubMed ID: 12383030
[TBL] [Abstract][Full Text] [Related]
11. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Goldstein I; Kim NN; Clayton AH; DeRogatis LR; Giraldi A; Parish SJ; Pfaus J; Simon JA; Kingsberg SA; Meston C; Stahl SM; Wallen K; Worsley R
Mayo Clin Proc; 2017 Jan; 92(1):114-128. PubMed ID: 27916394
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder.
Simon JA; Athavale A; Ravindranath R; Hadker N; Sadiq A; Lim-Watson M; Williams L; Krop J
J Womens Health (Larchmt); 2022 May; 31(5):715-725. PubMed ID: 35475708
[No Abstract] [Full Text] [Related]
13. The Role of Bupropion in the Treatment of Women with Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
Razali NA; Sidi H; Choy CL; Roos NAC; Baharudin A; Das S
Curr Neuropharmacol; 2022; 20(10):1941-1955. PubMed ID: 35193485
[TBL] [Abstract][Full Text] [Related]
14. Bremelanotide for Treatment of Female Hypoactive Sexual Desire.
Edinoff AN; Sanders NM; Lewis KB; Apgar TL; Cornett EM; Kaye AM; Kaye AD
Neurol Int; 2022 Jan; 14(1):75-88. PubMed ID: 35076581
[TBL] [Abstract][Full Text] [Related]
15. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA; Novick AM
J Midwifery Womens Health; 2021 Nov; 66(6):740-748. PubMed ID: 34510696
[TBL] [Abstract][Full Text] [Related]
16. Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT.
Pasha H; Basirat Z; Faramarzi M; Kheirkhah F
Int J Reprod Biomed; 2020 Mar; 18(3):175-186. PubMed ID: 32309766
[TBL] [Abstract][Full Text] [Related]
17. Effects of a food product (based on Daucus carota) and education based on traditional Persian medicine on female sexual dysfunction: a randomized clinical trial.
Molkara T; Akhlaghi F; Ramezani MA; Salari R; Vakili V; Kamalinejad M; Bordbar MRF; Ghorbani A; Motavasselian M
Electron Physician; 2018 Apr; 10(4):6577-6587. PubMed ID: 29881519
[TBL] [Abstract][Full Text] [Related]
18. An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.
Rogers RG; Pauls RN; Thakar R; Morin M; Kuhn A; Petri E; Fatton B; Whitmore K; Kingsberg SA; Lee J
Int Urogynecol J; 2018 May; 29(5):647-666. PubMed ID: 29577166
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and Management of Hypoactive Sexual Desire Disorder.
Clayton AH; Kingsberg SA; Goldstein I
Sex Med; 2018 Jun; 6(2):59-74. PubMed ID: 29523488
[TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.
Jayne CJ; Heard MJ; Zubair S; Johnson DL
Int J Womens Health; 2017; 9():171-178. PubMed ID: 28442935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
